Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Parasitic infection may be associated with discordant responses to QuantiFERON and tuberculin skin test in apparently healthy children and adolescents in a tuberculosis endemic setting, Ethiopia

Authors: Liya Wassie, Abraham Aseffa, Markos Abebe, Michael Z Gebeyehu, Martha Zewdie, Adane Mihret, Girum Erenso, Menberwork Chanyalew, Hiwot Tilahun, Lawrence K Yamuah, Peter Andersen, Mark T Doherty

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

M. tuberculosis remains one of the world’s deadliest pathogens in part because of its ability to establish persistent, latent infections, which can later reactivate to cause disease. In regions of the globe where disease is endemic, as much as 50% of the population is thought to be latently infected, complicating diagnosis and tuberculosis control. The tools most commonly used for diagnosis of latent M. tuberculosis infection are the tuberculin skin test and the newer interferon-gamma release assays, both of which rely on an antigen-specific memory response as an indicator of infection. It is clear that the two tests, do not always give concordant results, but the factors leading to this are only partially understood.

Methods

In this study we examined 245 healthy school children aged from 12 to 20 years from Addis Ababa, a tuberculosis-endemic region, characterised them with regard to response in the tuberculin skin test and QuantIFERON™ test and assessed factors that might contribute to discordant responses.

Results

Although concordance between the tests was generally fair (90% concordance), there was a subset of children who had a positive QuantIFERON™ result but a negative tuberculin skin test. After analysis of multiple parameters the data suggest that discordance was most strongly associated with the presence of parasites in the stool.

Conclusions

Parasitic gut infections are frequent in most regions where M. tuberculosis is endemic. This study, while preliminary, suggests that the tuberculin skin test should be interpreted with caution where this may be the case.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: Global Tuberculosis Control. Epidemiology, Strategy, Financing. 2009, Geneva: WHO World Health Organization: Global Tuberculosis Control. Epidemiology, Strategy, Financing. 2009, Geneva: WHO
2.
go back to reference Kabra SK, Lodha R, Seth V: Some current concepts on childhood tuberculosis. Indian J Med Res. 2004, 120 (4): 387-397.PubMed Kabra SK, Lodha R, Seth V: Some current concepts on childhood tuberculosis. Indian J Med Res. 2004, 120 (4): 387-397.PubMed
3.
go back to reference Federal Ministry of Health: Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme: Manual. 2008, Ethiopia, 4 Federal Ministry of Health: Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme: Manual. 2008, Ethiopia, 4
4.
go back to reference Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999, 282 (7): 677-686. 10.1001/jama.282.7.677.CrossRefPubMed Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999, 282 (7): 677-686. 10.1001/jama.282.7.677.CrossRefPubMed
5.
go back to reference Manabe YC, Bishai WR: Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med. 2000, 6 (12): 1327-1329. 10.1038/82139.CrossRefPubMed Manabe YC, Bishai WR: Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med. 2000, 6 (12): 1327-1329. 10.1038/82139.CrossRefPubMed
7.
go back to reference Salgame P: Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol. 2005, 17: 374-380. 10.1016/j.coi.2005.06.006.CrossRefPubMed Salgame P: Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol. 2005, 17: 374-380. 10.1016/j.coi.2005.06.006.CrossRefPubMed
8.
go back to reference Andersen P: Vaccine strategies against latent tuberculosis infection. Trends Microbiol. 2007, 15 (1): 7-13. 10.1016/j.tim.2006.11.008.CrossRefPubMed Andersen P: Vaccine strategies against latent tuberculosis infection. Trends Microbiol. 2007, 15 (1): 7-13. 10.1016/j.tim.2006.11.008.CrossRefPubMed
9.
go back to reference Kaufmann SHE, Parida KS: Tuberculosis in Africa: Learning from Pathogenesis for Biomarker Identification. Cell Host Microbe. 2008, 4: 219-228. 10.1016/j.chom.2008.08.002.CrossRefPubMed Kaufmann SHE, Parida KS: Tuberculosis in Africa: Learning from Pathogenesis for Biomarker Identification. Cell Host Microbe. 2008, 4: 219-228. 10.1016/j.chom.2008.08.002.CrossRefPubMed
11.
go back to reference Cheesbrough M: Formol ether concentration technique. Medical Laboratory Manual for Tropical Countries. Volume I. 1987, Oxford: Butterworth-heinemann Ltd, pp: 164-272. 2 Cheesbrough M: Formol ether concentration technique. Medical Laboratory Manual for Tropical Countries. Volume I. 1987, Oxford: Butterworth-heinemann Ltd, pp: 164-272. 2
12.
go back to reference CDC: Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000, 49 (RR-6): 1-51. CDC: Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000, 49 (RR-6): 1-51.
13.
go back to reference Abebe M, Doherty TM, Wassie L, Aseffa A, Bobosha K, Demissie A, Zewdie M, Engers H, Andersen P, Kim L, et al: Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status. Eur J Immunol. 2010, 40 (1): 291-301.CrossRefPubMed Abebe M, Doherty TM, Wassie L, Aseffa A, Bobosha K, Demissie A, Zewdie M, Engers H, Andersen P, Kim L, et al: Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status. Eur J Immunol. 2010, 40 (1): 291-301.CrossRefPubMed
14.
go back to reference Wassie L, Demissie A, Aseffa A, Abebe M, Yamuah L, Tilahun H, Petros B, Rook G, Zumla A, Andersen P, et al: Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time. PLoS One. 2008, 3 (1): e1522-10.1371/journal.pone.0001522.CrossRefPubMedPubMedCentral Wassie L, Demissie A, Aseffa A, Abebe M, Yamuah L, Tilahun H, Petros B, Rook G, Zumla A, Andersen P, et al: Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time. PLoS One. 2008, 3 (1): e1522-10.1371/journal.pone.0001522.CrossRefPubMedPubMedCentral
15.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed
16.
go back to reference Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC growth charts: United States. Adv Data. 2000, 314: 1-27.PubMed Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC growth charts: United States. Adv Data. 2000, 314: 1-27.PubMed
18.
go back to reference Bua A, Molicotti P, Delogu G, Pirina P, Mura MS, Madeddu G, Franca Saba F, Maida I, Sechi LA, Zanetti S: QuantiFERON TB Gold: a new method for latent tuberculosis infection. New Microbiol. 2007, 30 (4): 477-480.PubMed Bua A, Molicotti P, Delogu G, Pirina P, Mura MS, Madeddu G, Franca Saba F, Maida I, Sechi LA, Zanetti S: QuantiFERON TB Gold: a new method for latent tuberculosis infection. New Microbiol. 2007, 30 (4): 477-480.PubMed
19.
go back to reference Manuel O, Kumar D, et al: QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection. Expert Rev Mol Diagn. 2008, 8 (3): 247-256. 10.1586/14737159.8.3.247.CrossRefPubMed Manuel O, Kumar D, et al: QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection. Expert Rev Mol Diagn. 2008, 8 (3): 247-256. 10.1586/14737159.8.3.247.CrossRefPubMed
20.
go back to reference Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM: Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol. 2004, 172 (11): 6938-6943.CrossRefPubMed Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM: Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol. 2004, 172 (11): 6938-6943.CrossRefPubMed
21.
go back to reference John SH, Kenneth J, Gandhe AS: Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies. Biomarkers. 2012, 17 (1): 1-8. 10.3109/1354750X.2011.628048.CrossRefPubMed John SH, Kenneth J, Gandhe AS: Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies. Biomarkers. 2012, 17 (1): 1-8. 10.3109/1354750X.2011.628048.CrossRefPubMed
22.
go back to reference Abebe M, Doherty M, Wassie L, Demissie A, Mihret A, Engers H, Aseffa A: TB case detection: can we remain passive while the process is active?. Pan Afr Med J. 2012, 11: 50-PubMedPubMedCentral Abebe M, Doherty M, Wassie L, Demissie A, Mihret A, Engers H, Aseffa A: TB case detection: can we remain passive while the process is active?. Pan Afr Med J. 2012, 11: 50-PubMedPubMedCentral
23.
go back to reference Menzies D: Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999, 159 (1): 15-21. 10.1164/ajrccm.159.1.9801120.CrossRefPubMed Menzies D: Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999, 159 (1): 15-21. 10.1164/ajrccm.159.1.9801120.CrossRefPubMed
24.
go back to reference Elias D, Britton S, Aseffa A, Engers H, Akuffo H: Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine. 2008, 26 (31): 3897-3902. 10.1016/j.vaccine.2008.04.083.CrossRefPubMed Elias D, Britton S, Aseffa A, Engers H, Akuffo H: Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine. 2008, 26 (31): 3897-3902. 10.1016/j.vaccine.2008.04.083.CrossRefPubMed
25.
go back to reference Tegbaru B, Wolday D, Messele T, Legesse M, Mekonnen Y, Miedema F, van Baarle D: Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia. Clin Vaccine Immunol. 2006, 13 (7): 784-789. 10.1128/CVI.00098-06.CrossRefPubMedPubMedCentral Tegbaru B, Wolday D, Messele T, Legesse M, Mekonnen Y, Miedema F, van Baarle D: Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia. Clin Vaccine Immunol. 2006, 13 (7): 784-789. 10.1128/CVI.00098-06.CrossRefPubMedPubMedCentral
26.
go back to reference Dagnew AF, Hussein J, Abebe M, Zewdie M, Mihret A, Bedru A, Chanyalew M, Yamuah L, Medhin G, Bang P: Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth. BMC research notes. 2012, 5 (1): 415-10.1186/1756-0500-5-415.CrossRefPubMedPubMedCentral Dagnew AF, Hussein J, Abebe M, Zewdie M, Mihret A, Bedru A, Chanyalew M, Yamuah L, Medhin G, Bang P: Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth. BMC research notes. 2012, 5 (1): 415-10.1186/1756-0500-5-415.CrossRefPubMedPubMedCentral
27.
go back to reference Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, Ehrlich R, Hanekom WA, Hussey GD: The tuberculin skin test versus QuantiFERON TB Gold(R) in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One. 2011, 6 (3): e17984-10.1371/journal.pone.0017984.CrossRefPubMedPubMedCentral Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, Ehrlich R, Hanekom WA, Hussey GD: The tuberculin skin test versus QuantiFERON TB Gold(R) in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One. 2011, 6 (3): e17984-10.1371/journal.pone.0017984.CrossRefPubMedPubMedCentral
28.
go back to reference Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S: Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol. 2001, 123 (2): 219-225. 10.1046/j.1365-2249.2001.01446.x.CrossRefPubMedPubMedCentral Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S: Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol. 2001, 123 (2): 219-225. 10.1046/j.1365-2249.2001.01446.x.CrossRefPubMedPubMedCentral
29.
go back to reference Thomas TA, Mondal D, Noor Z, Liu L, Alam M, Haque R, Banu S, Sun H, Peterson KM: Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics. 2010, 126 (6): e1522-e1529. 10.1542/peds.2010-0885.CrossRefPubMedPubMedCentral Thomas TA, Mondal D, Noor Z, Liu L, Alam M, Haque R, Banu S, Sun H, Peterson KM: Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics. 2010, 126 (6): e1522-e1529. 10.1542/peds.2010-0885.CrossRefPubMedPubMedCentral
30.
go back to reference Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, Abebe F: Association of the level of IFN-gamma produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting. Int Immunol. 2012, 24 (2): 71-78.CrossRefPubMed Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, Abebe F: Association of the level of IFN-gamma produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting. Int Immunol. 2012, 24 (2): 71-78.CrossRefPubMed
31.
go back to reference Obihara CC, Beyers N, Gie RP, Hoekstra MO, Fincham JE, Marais BJ, Lombard CJ, Dini LA, Kimpen JL: Respiratory atopic disease, Ascaris-immunoglobulin E and tuberculin testing in urban South African children. Clin Exp Allergy. 2006, 36 (5): 640-648. 10.1111/j.1365-2222.2006.02479.x.CrossRefPubMed Obihara CC, Beyers N, Gie RP, Hoekstra MO, Fincham JE, Marais BJ, Lombard CJ, Dini LA, Kimpen JL: Respiratory atopic disease, Ascaris-immunoglobulin E and tuberculin testing in urban South African children. Clin Exp Allergy. 2006, 36 (5): 640-648. 10.1111/j.1365-2222.2006.02479.x.CrossRefPubMed
Metadata
Title
Parasitic infection may be associated with discordant responses to QuantiFERON and tuberculin skin test in apparently healthy children and adolescents in a tuberculosis endemic setting, Ethiopia
Authors
Liya Wassie
Abraham Aseffa
Markos Abebe
Michael Z Gebeyehu
Martha Zewdie
Adane Mihret
Girum Erenso
Menberwork Chanyalew
Hiwot Tilahun
Lawrence K Yamuah
Peter Andersen
Mark T Doherty
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-265

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.